4 Result(s)
within
Shengxiang Ren
Biomedicine
English
-
Article
Open AccessOn-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial
Camrelizumab plus chemotherapy significantly prolonged progression-free survival (PFS) and overall survival (OS) compared to chemotherapy alone as first-line treatment in advanced lung squamous cell carcinoma ...
-
Article
Open AccessOutcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
HER2 mutation has been found to be an oncogenic driver gene in non-small cell lung cancers(NSCLC) and HER2-directed therapies have shown promising results in this unique population, while little is known about it...
-
Article
Open AccessComprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
CD73 is one of the critical component in the formation of immunosuppressive microenvironment in cancers. We aimed to provide an overview of the current status of CD73 expression and its relationship with clini...
-
Article
Open AccessEpidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China
Human epidermal growth factor receptor (HER)-2 is a driver gene in non-small cell lung cancer (NSCLC). The present study evaluated the mutation rate of HER-2 within the wild-type epidermal growth factor receptor ...
